Panbela Therapeutics, Inc. PBLA
0.01 USD 0.00 (+0.00%)
At close·Nov 3, 2026, 4:00 PM EST
0.0001 52-week range 2.50
- YTD
- +5,450.00%
- 1 year
- -44.50%
Altman Z-Score
-60.79 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.0×
P/S 0.0×
P/B -12.1×
P/FCF -2.3×
EV/EBITDA -2.3×
EV/Sales 0.0×
FCF Yield -44.1%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 536.4%
ROIC -10520.5%
ROA -214.1%
Revenue 0.0%
Operating Income -50.5%
EPS (diluted) -470.4%
Free Cash Flow -58.4%
Current Ratio 0.2×
Quick Ratio 0.2×
Debt / Equity -1.1×
Net Debt / EBITDA -0.1×
Interest Coverage 162×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31